New Peer-Reviewed Publication Shows Multi-Omic AI-Powered Blood Test Detects Ovarian Cancer with High Accuracy in Symptomatic Women
AOA Dx (AOA), a company pioneering blood-based diagnostics for early cancer detection, has published peer-reviewed evidence demonstrating high accuracy in detecting ovarian cancer in symptomatic women, a population where early diagnosis is critical but often delayed.